Digestive Disease Interventions

LinksSchließen

Referenz

Lau D, Cunningham D, Gillbanks A. et al.
POLEM: avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III dMMR or POLE exonuclease domain mutant colon cancer—a phase III randomized study.

J Clin Oncol 2019;
37: TPS3615

Bibliographische Angaben herunterladen

Suchen in:

Aufrufen in: